| Jason E Gonzaga, MD | |
|
700 S Park St, Madison, WI 53715-1830 | |
| (608) 260-2900 | |
| (608) 260-2977 |
| Full Name | Jason E Gonzaga |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 18 Years |
| Location | 700 S Park St, Madison, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710026430 | NPI | - | NPPES |
| 1710026430 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 51710-20 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ssm Health St Mary's Hospital - Madison | Madison, WI | Hospital |
| Ssm Health St Mary's Hospital - Janesville | Janesville, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dean Health Systems Inc | 7012827983 | 1068 |
News Archive
The American Chemistry Council (ACC) issued the following statement in response to an article in the Journal of the American Medical Association (JAMA) by Leonardo Trasande, M.D., New York University, et al, and scheduled to be discussed at a media briefing on Tuesday, September 18.
Even if you are not overweight, your mannose levels may indicate whether you're at risk for type 2 diabetes (T2D) or insulin resistance (IR), a Swedish study shows.
The U.S. Food and Drug Administration today approved a device, called Xvivo Perfusion System with Steen Solution Perfusate, that can temporarily ventilate, oxygenate, and pump (perfuse) preservation solution through lungs that were initially thought to be unacceptable for transplant.
Moffitt Cancer Center, Sanford-Burnham Medical Research Institute and Florida Hospital have announced they will collaborate on the creation of a Personalized Medicine Partnership of Florida (PMP Florida). The partnership will conduct collaborative research to accelerate discovery and develop new treatments in the areas of cancer and metabolic diseases, including obesity, diabetes and cardiovascular disease.
› Verified 1 days ago
| Entity Name | Dean Health Systems Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053358846 PECOS PAC ID: 7012827983 Enrollment ID: O20031105000584 |
News Archive
The American Chemistry Council (ACC) issued the following statement in response to an article in the Journal of the American Medical Association (JAMA) by Leonardo Trasande, M.D., New York University, et al, and scheduled to be discussed at a media briefing on Tuesday, September 18.
Even if you are not overweight, your mannose levels may indicate whether you're at risk for type 2 diabetes (T2D) or insulin resistance (IR), a Swedish study shows.
The U.S. Food and Drug Administration today approved a device, called Xvivo Perfusion System with Steen Solution Perfusate, that can temporarily ventilate, oxygenate, and pump (perfuse) preservation solution through lungs that were initially thought to be unacceptable for transplant.
Moffitt Cancer Center, Sanford-Burnham Medical Research Institute and Florida Hospital have announced they will collaborate on the creation of a Personalized Medicine Partnership of Florida (PMP Florida). The partnership will conduct collaborative research to accelerate discovery and develop new treatments in the areas of cancer and metabolic diseases, including obesity, diabetes and cardiovascular disease.
› Verified 1 days ago
| Entity Name | The Medical College Of Wisconsin Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699720086 PECOS PAC ID: 2668384371 Enrollment ID: O20031120000259 |
News Archive
The American Chemistry Council (ACC) issued the following statement in response to an article in the Journal of the American Medical Association (JAMA) by Leonardo Trasande, M.D., New York University, et al, and scheduled to be discussed at a media briefing on Tuesday, September 18.
Even if you are not overweight, your mannose levels may indicate whether you're at risk for type 2 diabetes (T2D) or insulin resistance (IR), a Swedish study shows.
The U.S. Food and Drug Administration today approved a device, called Xvivo Perfusion System with Steen Solution Perfusate, that can temporarily ventilate, oxygenate, and pump (perfuse) preservation solution through lungs that were initially thought to be unacceptable for transplant.
Moffitt Cancer Center, Sanford-Burnham Medical Research Institute and Florida Hospital have announced they will collaborate on the creation of a Personalized Medicine Partnership of Florida (PMP Florida). The partnership will conduct collaborative research to accelerate discovery and develop new treatments in the areas of cancer and metabolic diseases, including obesity, diabetes and cardiovascular disease.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jason E Gonzaga, MD 700 S Park St, Madison, WI 53715-1830 Ph: (608) 260-2900 | Jason E Gonzaga, MD 700 S Park St, Madison, WI 53715-1830 Ph: (608) 260-2900 |
News Archive
The American Chemistry Council (ACC) issued the following statement in response to an article in the Journal of the American Medical Association (JAMA) by Leonardo Trasande, M.D., New York University, et al, and scheduled to be discussed at a media briefing on Tuesday, September 18.
Even if you are not overweight, your mannose levels may indicate whether you're at risk for type 2 diabetes (T2D) or insulin resistance (IR), a Swedish study shows.
The U.S. Food and Drug Administration today approved a device, called Xvivo Perfusion System with Steen Solution Perfusate, that can temporarily ventilate, oxygenate, and pump (perfuse) preservation solution through lungs that were initially thought to be unacceptable for transplant.
Moffitt Cancer Center, Sanford-Burnham Medical Research Institute and Florida Hospital have announced they will collaborate on the creation of a Personalized Medicine Partnership of Florida (PMP Florida). The partnership will conduct collaborative research to accelerate discovery and develop new treatments in the areas of cancer and metabolic diseases, including obesity, diabetes and cardiovascular disease.
› Verified 1 days ago
Prof. Marvin Lyle Birnbaum, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 3330 University Ave, Suite 300, Madison, WI 53705 Phone: 608-263-9641 Fax: 608-265-4429 | |
Yingyu Gao, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 600 Highland Ave, Madison, WI 53792 Phone: 608-263-6400 | |
Dr. Sam Joseph Lubner, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 600 Highland Ave, Madison, WI 53792 Phone: 608-265-1700 | |
Randy S Heidel, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 20 S Park St, Madison, WI 53715 Phone: 608-287-2250 Fax: 608-287-2438 | |
Benjamin Kleiber, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 700 S Park St, Dean & St. Mary's Outpatient Center, Madison, WI 53715 Phone: 608-260-2900 Fax: 608-260-2956 | |
N Thomas Casper, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3102 Meriter Way, Madison, WI 53719 Phone: 608-417-8800 | |
Philip Tepper Cohen, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 5154 Juneau Rd, Madison, WI 53705 Phone: 608-441-2512 Fax: 608-441-2512 |